HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic

Overview of attention for article published in Frontiers in endocrinology, November 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,166 followers.

HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic https://t.co/7k0WAam1Ua

04 Dec 2018

Reply Repost Favourite

HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic: Emily E. Morin, Xiang-An Li, Anna Schwendeman https://t.co/QJFL0oj3zB

03 Dec 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.